Pericardial effusion secondary prevention

Jump to navigation Jump to search

Pericardial effusion Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pericardial effusion from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Cardiac Catheterization

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Pericardial Window

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Pericardial effusion secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Pericardial effusion secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pericardial effusion secondary prevention

CDC on Pericardial effusion secondary prevention

Pericardial effusion secondary prevention in the news

Blogs on Pericardial effusion secondary prevention

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Pericardial effusion secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hafiz M. Ahmed, M.D.[2]

Overview

Secondary prevention of pericardial effusion focuses on preventing recurrence, progression to cardiac tamponade, and complications related to the underlying pericardial disease. Strategies include treatment of the underlying cause, appropriate anti-inflammatory therapy when effusion is associated with active pericarditis, and echocardiographic surveillance for at least moderate-sized effusions when clinically appropriate.

Secondary Prevention

  • The underlying cause of pericardial effusion should be identified and treated when possible.
  • Inflammatory pericardial effusion without concern for cardiac tamponade should generally be treated with anti-inflammatory therapy before pericardiocentesis is considered.
  • Transthoracic echocardiography may be used for surveillance of pericardial effusions that are at least moderate in size.
  • Patients with recurrent large pericardial effusion and/or recurrent cardiac tamponade despite prior pericardiocentesis may be considered for surgical pericardial window.
  • In rare cases, recurrent effusion despite pericardial window may require consideration of radical pericardiectomy, particularly when medically refractory constrictive pericarditis or recurrent pericarditis is also present.[1]

References

  1. ↑ Wang TKM, Klein AL, Cremer PC, Imazio M, Kohnstamm S, Luis SA, Mardigyan V, Mukherjee M, Ordovas K, Vakamudi S, Wohlford GF. 2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on the Diagnosis and Management of Pericarditis: A Report of the American College of Cardiology Solution Set Oversight Committee. Journal of the American College of Cardiology. 2025;86(25):2691-2719. https://doi.org/10.1016/j.jacc.2025.05.023.

Template:WH Template:WS